| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/28/2023 | 18.89% | Wells Fargo | $28 → $27 | Upgrades | Equal-Weight → Overweight |
| 08/04/2023 | 23.29% | Wells Fargo | $35 → $28 | Maintains | Equal-Weight |
| 04/18/2023 | 62.92% | Barclays | $40 → $37 | Maintains | Underweight |
| 02/02/2023 | 76.13% | Barclays | $39 → $40 | Maintains | Underweight |
| 01/18/2023 | 71.73% | Barclays | → $39 | Downgrades | Equal-Weight → Underweight |
| 01/10/2023 | 84.94% | Wells Fargo | $41 → $42 | Maintains | Equal-Weight |
| 11/23/2022 | 80.54% | B of A Securities | $43 → $41 | Downgrades | Neutral → Underperform |
| 11/21/2022 | 71.73% | Wells Fargo | $36 → $39 | Maintains | Equal-Weight |
| 10/19/2022 | 58.52% | Wells Fargo | $42 → $36 | Maintains | Equal-Weight |
| 10/19/2022 | 58.52% | Barclays | $40 → $36 | Maintains | Equal-Weight |
| 08/08/2022 | 84.94% | Wells Fargo | $41 → $42 | Maintains | Equal-Weight |
| 04/29/2022 | 76.13% | Wells Fargo | $46 → $40 | Maintains | Equal-Weight |
| 03/07/2022 | 67.33% | B of A Securities | $46 → $38 | Downgrades | Buy → Neutral |
| 10/20/2021 | 102.55% | Wells Fargo | → $46 | Initiates Coverage On | → Equal-Weight |
| 06/23/2021 | 124.57% | B of A Securities | → $51 | Upgrades | Neutral → Buy |
| 07/24/2020 | 98.15% | Jefferies | $46 → $45 | Maintains | Buy |
| 07/16/2020 | 62.92% | Barclays | → $37 | Upgrades | Underweight → Equal-Weight |
| 05/11/2020 | 58.52% | UBS | $35 → $36 | Maintains | Buy |
| 05/07/2020 | 54.12% | UBS | $36 → $35 | Maintains | Buy |
| 05/07/2020 | 32.1% | Barclays | $29 → $30 | Maintains | Underweight |
| 04/01/2020 | 58.52% | UBS | $37 → $36 | Maintains | Buy |
| 03/30/2020 | 62.92% | UBS | $45 → $37 | Maintains | Buy |
| 12/04/2019 | 137.78% | UBS | $56 → $54 | Maintains | Buy |
| 11/12/2019 | 146.59% | UBS | $58 → $56 | Maintains | Buy |
| 10/17/2019 | 155.39% | UBS | $60 → $58 | Maintains | Buy |
| 04/05/2019 | 164.2% | Jefferies | $54 → $60 | Upgrades | Hold → Buy |
| 02/25/2019 | — | UBS | Upgrades | Neutral → Buy | |
| 12/14/2018 | 177.41% | UBS | $65 → $63 | Downgrades | Buy → Neutral |
| 10/12/2018 | 133.38% | Barclays | $50 → $53 | Maintains | Underweight |
What is the target price for UGI (UGI)?
The latest price target for UGI (NYSE: UGI) was reported by Wells Fargo on August 28, 2023. The analyst firm set a price target for $27.00 expecting UGI to rise to within 12 months (a possible 18.89% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for UGI (UGI)?
The latest analyst rating for UGI (NYSE: UGI) was provided by Wells Fargo, and UGI upgraded their overweight rating.
When is the next analyst rating going to be posted or updated for UGI (UGI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UGI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UGI was filed on August 28, 2023 so you should expect the next rating to be made available sometime around August 28, 2024.
Is the Analyst Rating UGI (UGI) correct?
While ratings are subjective and will change, the latest UGI (UGI) rating was a upgraded with a price target of $28.00 to $27.00. The current price UGI (UGI) is trading at is $22.71, which is out of the analyst's predicted range.